Panoptica's Series B - II Round

Panoptica raised a round of funding on October 06, 2017.

PanOptica is a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies. PanOptica has identified and evaluated more than 200 biopharmaceutical assets w…

Articles about Panoptica's Series B - II Round: